Latest Leverage News

Kalgoorlie Gold Mining has significantly expanded its primary gold mineralisation footprint at the Lighthorse prospect, while advancing resource updates at Bulong Taurus and maintaining a strong balance sheet.

Gold Hydrogen Limited has reported successful drilling results confirming high-purity Natural Hydrogen and Helium at its Ramsay Project in South Australia, setting the stage for commercial pilot testing and green methanol development.

Reward Minerals has completed the acquisition of the Copper Lance project in Canada and progressed multiple Australian exploration projects while advancing its proprietary potash processing technologies.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Liontown Limited has successfully transitioned to 100% underground mining at Kathleen Valley, delivering a 37% increase in underground production and a 91% jump in quarterly revenue. The company is on track to reduce costs and boost recoveries as it targets a steady-state underground run-rate.

Zimi Limited has reported a striking 300% year-on-year revenue surge alongside the industrialisation of its next-generation Senoa Matter smart home range, signalling a pivotal moment in its growth and market positioning.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Aeris Resources delivered solid Q2 FY26 results with copper equivalent production of 10.1kt at competitive costs, strengthened its balance sheet by repaying debt, and reported promising exploration outcomes that could underpin future growth.

SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.